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Abstract
Objectives Patients with prosthetic heart valves may re-
quire assessment for coronary artery disease. We assessed
whether valve artefacts hamper coronary artery assessment
by multidetector CT.
Methods ECG-gated or -triggered CT angiograms were
selected from our PACS archive based on the presence of
prosthetic heart valves. The best systolic and diastolic axial
reconstructions were selected for coronary assessment. Each
present coronary segment was scored for the presence of
valve-related artefacts prohibiting coronaryartery assessment.
Scoring was performed in consensus by two observers.
Results Eighty-two CT angiograms were performed on a
64-slice (n027) or 256-slice (n055) multidetector CT.
Eighty-nine valves and five annuloplasty rings were present.
Forty-three out of 1160 (3.7%) present coronary artery seg-
ments were non-diagnostic due to valve artefacts (14/82
patients). Valve artefacts were located in right coronary
artery (15/43; 35%), left anterior descending artery (2/43;
5%), circumflex artery (14/43; 32%) and marginal obtuse
(12/43; 28%) segments. All cobalt-chrome containing
valves caused artefacts prohibiting coronary assessment.
Biological and titanium-containing valves did not cause
artefacts except for three specific valve types.
Conclusions Most commonly implanted prosthetic heart
valves do not hamper coronary assessment on multidetector
CT. Cobalt-chrome containing prosthetic heart valves pre-
clude complete coronary artery assessment because of se-
vere valve artefacts.
Key Points
￿ Most commonly implanted prosthetic heart valves do not
hamper coronary artery assessment
￿ Prosthetic heart valve composition determines the occur-
rence of prosthetic heart valve-related artefacts
￿ Björk–ShileyandSorintiltingdiscvalvesprecludediagnostic
coronary artery segment assessment
Keywords Computedtomography.Prostheticheartvalve.
Coronary arterydisease.Coronaryartery.Artefacts
Introduction
The introduction of ECG-gated and triggered multidetector
computed tomography (MDCT) technology has resulted in
new diagnostic cardiac applications, most noticeably cor-
onary artery assessment [1]. Recently, MDCT has also
shown potential for the evaluation of prosthetic heart valve
(PHV) (dys)function by providing complementary diag-
nostic information to echocardiography and fluoroscopy,
especially in patients with suspected PHVobstruction and
PHVendocarditis [2–6].
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tion, MDCT may have complementary clinical value for the
surgical planning in patients considered for reoperation after
previous PHV implantation. MDCT can be used to evaluate
the presence of coronary artery disease (CAD) and the
patency of present bypass grafts to serve as an alternative
for classical coronary angiography, and the distance be-
tween the sternum and the right ventricle can be measured
[7]. Patients with a normal functioning PHV may also be
candidates for CT assessment of the coronary arteries in
newly developed angina.
Each PHV type has its own specific imaging character-
istics on CT [8, 9]. Most PHVs have limited artefacts but at
present little is known about which PHV types and positions
induce artefacts to such an extent that they prohibit coronary
assessment on MDCT. Knowledge of which PHV types and
positions prohibit coronary assessment is clinically impor-
tant to determine whether adequate CT assessment of coro-
nary segments is to be expected or that the patient should be
referred for conventional coronary angiography straight
away. The purpose of this study was to determine which
PHV types induce artefacts that hamper coronary artery
segment assessment on MDCT in a cohort of patients with
a PHV in whom an ECG-gated or -triggered PHV had been
performed.
Materials and methods
CT angiogram selection
We reviewed all ECG-gated or prospectively triggered PHV
CTangiograms (CTAs) performed in the University Medical
Center Utrecht and Academic Medical Center Amsterdam
between 2003 and September 2011 for the presence of
PHVs that were imaged in both systolic and diastolic phase.
We excluded CTAs that included only systolic or diastolic
imaging, were performed on 16-slice MDCT, non-contrast
enhanced imaging as well as CTAs in patients enrolled in an
ongoing prospective diagnostic cross-sectional study on CT
PHV assessment. Furthermore, patients with multiple CTA
examinations were included only once. Patients with a con-
comitant mitral or tricuspid annuloplasty ring were included.
CTAs were performed on 64 or 256 slice MDCT systems
(Brilliance 64 and iCT, Philips Medical Systems, Cleveland,
Ohio). Contrast agents [Ultravist (iopromide) - 300 mg I/mL,
Bayer Schering Pharma AG, Berlin, Germany or Iomeron
(iomeprol) - 400 mg I/mL, Bracco UK Limited, London,
United Kingdom] were administered in all patients. Cardiac
CTAs were performed with a triphasic or dual phasic contrast
injection protocol. The triphasic protocol started with a 100%
contrast injection (phase 1) followed by a 30%/70% contrast/
saline mixture (phase 2), and concluded with a saline flush
(phase 3). Contrast volumes were adjusted for the patients
body weight with an iodine flow of 1.6 g/s for patients <70
kilogram (kg), 1.8 g/s for patients 70–85 kg and 2.0 g/s for
patients >85 kg. The dual phase contrast protocol consisted of
a contrast injection of 100 millilitre (mL) followed by a saline
flush. For aortic CTAs, a fixed bolus of 100 ml was followed
by a saline flush of 50 ml. In general, injection flow was set to
5–6 ml/s. The CTA selection resulted in the inclusion of 82
patients (48 males, 34 females) with 94 PHVs and annulo-
plasty rings. The mean age of our study population was 58±
14 years (mean ± SD). All 82 patients underwent CTA exami-
nations on 64-slice (n027) or 256-slice (n055) MDCT sys-
tems. The indications for CTA examinations were: PHV
dysfunction(n047),aorticaneurysmevaluation(n017), aortic
dissection (n08), coronary assessment (n03), cardiac other
(n05) and other (n02). In four of 82 patients (5%) beta-
blockers were administered to lower the heart rate. Nitroglyc-
erin was not routinely administered in our patients.
CT data were retrieved from the PACS archive of the
Radiology department and sent to a dedicated workstation
for image analysis. Heart rate during imaging was obtained
from the CT data. DLP values were obtained if dose infor-
mation was available. DLP values were converted to radia-
tion exposure (mSv) by using 0.017 for cardiac CTAs, and
0.016 (mean of 0.017 for the chest and 0.015 for the abdo-
men) for thoraco-abdominal aortic CTAs as conversion fac-
tor. Patient and PHV data were obtained from the patient’s
medical files. The study was performed under a waiver from
the institutional reviewing board. Data on the image quality
of the PHV itself in a number of these patients have been
previously published [9].
Fig. 1 Coronary artery segments according to the American Heart
Association classification [10]. Ao 0 Aorta; RCA 0 Right Coronary
Artery; LCA 0 Left Coronary Artery; LM 0 Left Main branch; LAD 0
Left Anterior Descending Coronary Artery; LCX 0 Left Circumflex
Coronary Artery
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Manufacturer Type PHV type Number per valve position (number of valves that cause PHV-related artefacts)
Aortic Mitral Pulmonary Tricuspid Total
Carbomedics Mechanical Bileaflet 21 (0) 3 (1) 0 (0) 0 (0) 24 (1)
St Jude Mechanical 8 (2) 4 (3) 0 (0) 0 (0) 12 (5)
ON-X Mechanical 5 (0) 0 (0) 0 (0) 1 (0) 6 (0)
Sorin bileaflet Mechanical 5 (3) 1 (0) 1 (1) 0 (0) 7 (4)
Duromedics Mechanical 0 (0) 1 (1) 0 (0) 0 (0) 1 (1)
Medtronic Hall Mechanical Tilting disc 9 (0) 3 (0) 0 (0) 0 (0) 12 (0)
Sorin monoleaflet Mechanical 1 (1) 1 (1) 0 (0) 0 (0) 2 (2)
Björk–Shiley Mechanical 3 (3) 1 (1) 0 (0) 0 (0) 4 (4)
CE Annuloplasty ring 0 (0) 4 (0) 0 (0) 1 (0) 5(0)
Perimount Biological 15 (0) 0 (0) 0 (0) 0 (0) 15 (0)
Mitroflow Biological 1 (0) 0 (0) 0 (0) 0 (0) 1 (0)
Medtronic mosaic Biological 2 (0) 0 (0) 0 (0) 0 (0) 2 (0)
Freestyle Biological 1 (0) 0 (0) 0 (0) 0 (0) 1 (0)
Epic St Jude Biological 2 (0) 0 (0) 0 (0) 0 (0) 2 (0)
Total 73 (9) 18 (7) 1 (1) 2 (0) 94 (17)
The number of PHVs causing artefacts prohibiting assessment of at least one coronary artery segment are presented in parentheses
Table 2 Coronary artery segments and valve-related artefacts specified per prosthetic heart valve (PHV) manufacturer type in aortic position
PHV position PHV manufacturer PHV type Present segments*/
non-assessable due
to PHVartefacts
Non-diagnostic coronary
segments due to PHV
artefacts
Carbomedics 307/0 None
Aortic St Jude Bileaflet 117/2 2× RCA segment 1
Sorin 77/3 2× RCA segment 1
1× LCX segment 11
ON-X 69/0 None
Medtronic Hall Tilting disc 127/0 None
Björk–Shiley 34/11 3× RCA segment 1
3× RCA segment 2
1× LCX segment 11
1× MO segment 12
2× LCX segment 13
1×MO segment 14
Sorin 16/2 1×RCA segment 1
1×RCA segment 2
CE Perimount Biological 218/0 None
Medtronic Mosaic 31/0 None
Freestyle 15/0 None
Mitroflow 16/0 None
Epic St Jude 27/0 None
* Total number of present segments in Tables 1, 2 and 3 is higher than 1160 owing to multiple assessment of coronary segments in patients with
multiple PHVs as the segments are presented for each PHV separately
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Assessment of the MDCT was performed on a dedicated
workstation (Extended Brilliance Workstation, Philips
Healthcare, Best, The Netherlands). The best systolic and
diastolic image phase in the retrospectively gated or pro-
spectively triggered CT dataset for coronary assessment was
selected. Coronary arteries were assessed according to the
17-segment modified American Heart Association classifi-
cation [10] on the axial images (Fig. 1).
First, each coronary segment was scored as present or
absent. Absent was defined as no visible segment, but
sufficient high image quality to exclude non-visibility of
other causes or a segment not included in the imaging range.
For present segments, the image quality was scored on a
three-point scale (10non-diagnostic, 20acceptable, 30
good). The criteria for the different scores were formulated
as follows: (1) non-diagnostic: segment details not sufficient
visualised to perform diagnostic assessment; (2) acceptable:
adequate segment details with limited artefacts; and (3)
good: perfect segment details without artefacts. Reasons
for non-diagnostic segments were classified as: valve- or
ring annuloplasty-related artefacts, or other (e.g. motion,
small vessel size, low contrast enhancement and pacemaker
lead artefacts). Scoring was performed in consensus by two
observers (JH and RB) with 2 years and 5 years experience
in CT coronary assessment, respectively.
Data analysis
Data analysis was restricted to descriptive statistics. Data
were presented as means ± standard deviation (SD) for
continuous data with a parametric data distribution. Cate-
gorical data were presented in total numbers and/or percen-
tages. The presence of PHV-related artefacts precluding
coronary artery segment assessment was determined for
Table 3 Coronary artery segments and valve-related artefacts specified per PHV manufacturer type in other positions
PHV position PHV manufacturer PHV type Present segments*/
non-assessable due
to PHVartefacts
Non-diagnostic coronary
segments due to PHV
artefacts
Mitral Carbomedics Bileaflet 46/1 1×LCX segment 13
St Jude 51/6 1×LCX segment 11
1×MO segment 12
1×LCX segment 13
3× MO segment 14
Duromedics 11/4 1×LCX segment 11
1×MO segment 12
1×LCX segment 13
1×MO segment 14
Sorin 15/0 None
CE Mitral ring Annuplasty ring 62/0 None
Medtronic Hall Tilting disc 46/0 None
Björk–Shiley 14/6 1×RCA segment 2
1×RCA segment 3
1×LAD segment 8
1×MO segment 12
1×LCX segment 13
1×MO segment 14
Sorin 16/5 1×LAD segment 8
1×LCX segment 11
1×MO segment 12
1×LCX segment 13
1×MO segment 14
Pulmonary Sorin Bileaflet 15/1 1×RCA segment 2
Tricuspid ON-X Bileaflet 15/0 None
CE Tricuspid ring Annuplasty ring 15/0 None
* Total number of present segments in Tables 1, 2 and 3 is higher than 1160 owing to multiple assessment of coronary segments in patients with
multiple PHVs as the segments are presented for each PHV separately
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related artefacts are presented per coronary artery segment.
Results
Mean heart rate during the 82 CTA examinations was 73±18
beats per minute (bpm). In 15 of the 82 patients (18%), the
heart rate during CT data acquisition was missing. Mean heart
rates were 73±18 bpm and 72±19 bpm for the mechanical
PHV group and biological PHV group, respectively. Sixty of
82 (73%) CT acquisitions were performed as a dedicated
cardiac CTA including 51 retrospectively ECG-gated CTAs
(120 kV, ≥600 mAs) and nine prospectively triggered CTAs
(120 kV, 200–250 mAs); and 22/82 (27%) CTAs as a retro-
spectively ECG-gated CTA of the thoraco-(abdominal) aorta
with a lower tube current (200–400 mAs). Radiation dose
information was available for 42/82 patients (51%). Mean
radiation dose for retrospectively ECG-gated cardiac CTAs
was 15.6±5.5 mSv, and for thoraco-abdominal aortic CTAs
17.6±4.2 mSv. Ninety-four PHVs and annuloplasty rings of
14differentPHVandannuloplastyringtypeswerepresent:68
mechanical PHVs (72%), 21 biological PHVs (22%), and 5
annuloplasty rings (5%) (mitral n04 and tricuspid n01).
PHVs and annuloplasty rings were positioned in the aortic
(n073; 78%), mitral (n018; 19%), pulmonary (n01; 1%) and
tricuspid (n02; 2%) positions (Table 1).
PHV-related artefacts interfering with coronary artery
assessment on MDCT
In total 17/94 (18%) PHVs and annuloplasty rings induced
artefacts prohibiting assessment of at least one coronary
segment (Table 1). Valve-related artefacts per coronary seg-
ment are shown in Tables 2 and 3.
A theoretical total of 1394 coronary segments (82
patients×17 segments) were available for analysis. Two
hundred and thirty-four of the 1394 segments (17%) were
scored absent. In total 1160 coronary segments were present
for assessment. Three-hundred and six of 1160 coronary
segments (26%) demonstrated a non-diagnostic image qual-
ity, 538/1160 (46%) had acceptable image quality; and in
Fig. 3 a Sorin tilting disc
Prosthetic Heart Valve (PHV) in
the aortic position, which
causes PHV-related artefacts in
RCA segment 1. b ON-X
bileaflet Prosthetic Heart Valve
(PHV) in the aortic position,
which causes no PHV-related
artefacts in RCA segment 1
Fig. 2 Distribution of non-
diagnostic coronary segments
in patients with prosthetic
heart valves
1282 Eur Radiol (2012) 22:1278–1286316/1160 (27%) image quality was good. The reasons for
non-diagnostic image quality were PHV-related artefacts
(n043; 14%), motion (n060 segments; 20%), vessel size
(n0192; 63%); and pacemaker artefacts (n011; 4%)
(Fig. 2). In patients with more than one PHV implanted,
no coronary segments were non-assessable owing to arte-
facts originating from both valves.
None of the biological PHVs (0/21; 0%) and annulo-
plasty rings (0/5; 0%), and none of the ON-X (0/6; 0%)
and Medtronic Hall (0/12; 0%) mechanical PHVs caused
artefacts prohibiting coronary assessment.
In the aortic position, St Jude (2/8; 25%) and Sorin (3/5;
60%) bileaflet PHVs caused artefacts prohibiting coronary
assessment, mainly of the proximal right coronary artery
(RCA). The Björk–Shiley (n03; 100%) and Sorin tilting disc
PHVs (n01;100%) causedsevereartefacts inRCAsegments.
Moreover, the Björk–Shiley tilting disc also caused artefacts
in the left circumflex (LCX) and obtuse marginal (MO)
branches (Table 2). The commonly implanted PHVs (Carbo-
medics bileaflet (n021; 0%) and Medtronic Hall tilting disc
(n09;0%)demonstratednoPHV-relatedartefactsintheaortic
position (Tables 1 and 2). Figures 3 and 4 illustrate aortic
PHVs with and without PHV-related artefacts in the RCA.
In the mitral position, Carbomedics (1/3; 33%), St Jude
(3/4; 75%) and the Duromedics (1/1; 100%) bileaflet PHVs
caused artefacts prohibiting assessment of at least one coro-
nary segment in the LCX and MO branches. Both Björk–
Shiley and the Sorin tilting disc PHVs caused severe artefacts
in LCX and MO segments. The Björk–Shiley tilting disc also
caused severe artefacts in RCA segments. Affected segments
are detailed in Table 3.F i g u r e5 illustrates mitral PHVs with
and without artefacts in the LCX. In the pulmonary position,
the Sorin bileaflet PHV (n01; 100%) demonstrated PHV-
related artefacts in RCA segment 2. In the tricuspid position,
ON-X bileaflet PHV (n01) and tricuspid annuplasty ring
(n01) showed no PHV-related artefacts (Table 3).
PHV related artefacts in different imaging phases
In all patients, coronary artery segments were assessed in the
best systolic and diastolic imaging phase. In the aortic posi-
tion, four patients (5%) demonstrated PHV-related artefacts
precludingdiagnosticcoronaryassessmentofRCA segment1
only in diastolic (n02; 50%) or systolic (n02; 50%) phase. In
the mitral position, one patient (6%) had only PHV-related
artefacts in the diastolic phase in the LCX and MO branches.
Fig. 5 a Björk–Shiley tilting
disc Prosthetic Heart Valve
(PHV) in the mitral position,
which causes PHV-related
artefacts in LCX. b Medtronic
Hall tilting disc PHV in the
mitral position, which causes no
PHV-related artefacts in LCX
Fig. 4 St Jude bileaflet Prosthetic Heart Valve (PHV) in the aortic
position, which causes PHV-related artefacts in RCA segment 1
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segments (1, 2 and 3), left anterior descending artery (LAD)
segment 8, LCX segments (11 and 13), and MO branches
(12 and 14). The close relationship between RCA and aortic
PHV, and LCX and mitral PHV is illustrated in Fig. 6. The
assessment of the remaining coronary segments (including
the left main branch, Fig. 7) was not disturbed by PHV-
related artefacts (Fig. 1, Tables 2 and 3).
Discussion
The principle findings of our study are: (1) the diagnostic
assessment of most coronary artery segments in patients with
PHVs was not hampered by PHV-related artefacts, (2) Björk–
Shiley tilting disc PHVs, Sorin tilting disc PHVs and Duro-
medics bileaflet PHVs precluded complete diagnostic assess-
ment of coronary artery segments; and (3) ON-X and
Medtronic Hall PHVs, biological PHVs and annuloplasty
rings never hampered coronary artery assessment by MDCT.
The PHV-related artefacts on MDCT images seem to be
more dependent on PHV composition than on the PHV
design (bileaflet, tilting disc and biological valves) (Table 4)
[8, 9]. As far as the material of the PHV is concerned our
study showed notable differences.
Björk–Shiley and Sorin tilting disc PHVs as well as
Duromedics bileaflet PHVs demonstrated severe artefacts
which precluded diagnostic coronary assessment of RCA,
LCX and the distal segment of the LAD, dependent on the
PHV position. This finding is supported by previous studies
that described that these PHV types as being associated with
valve-related artefacts that also prohibit the evaluation of the
PHV itself on MDCT [8, 9, 11, 12]. The severe artefacts of
the Björk–Shiley, Sorin tilting disc and Duromedics bileaflet
PHVs were caused by the cobalt-chrome alloy that is present
in these valves. Therefore, MDCT is not suitable for the
assessment of the coronary arteries in patients who have one
of these PHVs implanted. The Saint Jude PHV, consisting of
a nickel alloy, produced fewer artefacts but still enough to
preclude assessment of a limited number of coronary artery
segments in the right coronary artery and circumflex terri-
tory (segments 1, 13 and 14). The other segments did not
suffer from artefacts that precluded assessment. The Saint
Jude PHV is one of the most commonly implanted PHV
types worldwide and therefore one of the most likely PHVs
to be encountered. The possibility of the non-diagnostic
image quality of the above-mentioned segments should be
kept in mind when performing cardiac CT in these patients.
In general, Carbomedics, ON-X and Medtronic Hall me-
chanical PHVs caused no PHV-related artefacts hampering
Fig. 6 Cardiac valvular anatomy with a St Jude Prosthetic Heart Valve
(PHV) in the mitral position. The illustration demonstrates the close
relationship between the LCX and the mitral PHV
Fig. 7 Carbomedics bileaflet Prosthetic Heart Valve (PHV) in the aortic
position, which causes no PHV-related artefacts in the LM branch
Table 4 Metallic properties of different prosthetic heart valves (PHV)
PHV manufacturer PHV design Metallic contents
*
Carbomedics Mechanical bileaflet Titanium alloy
St Jude Mechanical bileaflet Nickel alloy
ON-X Mechanical bileaflet Titanium alloy
Sorin bileaflet Mechanical bileaflet Titanium alloy
Duromedics Mechanical bileaflet Cobalt-chrome alloy
Medtronic Hall Mechanical tilting disc Titanium alloy
Sorin monoleaflet Mechanical tilting disc Cobalt-chrome alloy
Björk–Shiley Mechanical tilting disc Cobalt-chrome alloy
CE Annuloplasty ring Elgiloy
CE Perimount Biological Elgiloy
Sorin Mitroflow Biological -
Medtronic Mosaic Biological Haynes® alloy
(stent post markers)
Medtronic Freestyle Biological -
St Jude Epic Stented Biological Stainless steel wire in
sewing cuff
*Manufacturer data
1284 Eur Radiol (2012) 22:1278–1286coronary artery assessment. These PHVs are mainly com-
posed of titanium alloys that are associated with only limited
artefacts on MDCT [8].
The biological PHVs and annuloplasty rings produced
fewer PHV artefacts than mechanical PHVs on MDCT.
Some biological PHVs have a radiopaque frame that sup-
ports the valve leaflets, but this does not generally induce
many artefacts [2, 9]. In our study, no PHV-related artefacts
that interfered with diagnostic coronary assessment were
found in biological PHVs or annuloplasty rings.
Prosthetic heart valves in the aortic position may show
mainly artefacts in the proximal RCA (segments 1 and 2)
because of the close relationship between the aortic PHVand
the proximal RCA. Interestingly, the left main branch, which
alsohas a close relationshipwith the aorticPHV, did not show
anyPHV-relatedartefacts.ThereasonfortheabsenceofPHV-
related artefacts in this segment may be the angulation of the
PHV with respect to the X-ray beam of the gantry.
In the mitral position, PHV-related artefacts occurred in
the LCX and MO branches. The close relationship between
these segments and the mitral PHV position is a likely
explanation for the presence of the PHV-related artefacts
in these specific segments.
Limitations
Our study contains many different PHV types. A few PHV
types are only represented in small numbers. However the
most commonly implanted PHVs (Carbomedics, St Jude,
Medtronic Hall and the Perimount biological PHVs) are
present in considerable numbers. The mean heart rate of
73±18 bpm is relatively high for CT coronary assessment
because 79 of 82 CTAs (96%) were performed for other
clinical indications without a specific heart rate reduction.
High heart rates may cause considerable motion artefacts
that influence diagnostic CAD assessment. However, the
specific interest of this study was to address the question:
do PHV-related artefacts disturb coronary assessment?
Other reports emphasised the importance of an optimal heart
rate and the restricted diagnostic value of MDCT in the
detection of CAD in distal coronary segments [13]. To
optimize coronary image quality, beta-blockers and nitro-
glycerin should be routinely administered in patients with-
out contraindications for these drugs. In this study, CT
coronary angiography was not compared with conventional
coronary angiography. Further prospective studies are re-
quired to determine the diagnostic accuracy of CT coronary
angiography in patients after PHV implantation. However,
as most commonly implanted PHV types generate only
limited artefacts, we would expect the diagnostic accuracy to
be close to published results in patients who have not yet
undergone PHV implantation [13]. Consensus reading was
performed. Interobserver variability has to be investigated in
further studies to validate the PHV-related artefacts scoring
system. Axial CT images only were assessed for the presence
ofPHV-relatedartefacts.Multiplanarreconstructionswerenot
separately assessed because PHV-related artefacts were pres-
ent in both axial and multiplanar reconstructions.
In conclusion, the most commonly implanted PHVs do not
cause artefacts that prohibit coronary artery assessment of at
least one coronary segment by MDCT. Carbomedics, Med-
tronic Hall and ON-X mechanical PHVs, bioprosthesis, and
annuloplasty rings virtually never hamper coronary artery as-
sessment by MDCT. However, in patients with a Björk–Shiley
or Sorin tilting PHV, coronary artery assessment by MDCT is
virtually always hampered by PHV induced artefacts.
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